Taro Pharmaceutical Industries Ltd.
TARO · NYSE
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15 | $20 | $9 | $10 |
| Dep. & Amort. | $8 | $7 | $8 | $8 |
| Deferred Tax | $14 | $3 | $0 | $2 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $3 | $5 | $30 | -$9 |
| Other Non-Cash | -$10 | -$4 | $1 | -$4 |
| Operating Cash Flow | $44 | $31 | $48 | $8 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$34 | -$7 | -$7 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$2 | $0 | $32 | -$32 |
| Inv. Sales/Matur. | -$43 | $116 | $74 | $0 |
| Other Inv. Act. | -$51 | $116 | $0 | -$32 |
| Investing Cash Flow | -$52 | $82 | $99 | -$39 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | -$1 | $1 | -$1 | $1 |
| Net Chg. in Cash | -$20 | $113 | $145 | -$30 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $382 | $269 | $124 | $154 |
| End Cash | $363 | $382 | $269 | $124 |
| Free Cash Flow | $36 | -$4 | $41 | $1 |